Oxaliplatin

May 29, 2020

Development of Drug Resistance in Colon Cancer Patients Contributed to Failure of Oxaliplatin-based HIPEC PRODIGE 7 Trial

Feb 18, 2020

The First Patient Included in Japan in Isofol's Phase 3 AGENT Study

Dec 20, 2019

Patent Approved in Japan for Isofol's Drug Candidate Arfolitixorin

Jun 25, 2019

Isofol Receives Clinical Use Patent Approval in the United States for Drug Candidate arfolitixorin

May 08, 2019

Isofol Reports 58 % Overall Response Rate in Patients with Metastatic Colorectal Cancer in Phase 1/2a Open Label Extension Study with Arfolitixorin

Jan 17, 2019

Isofol Reports Early Tumor Shrinkage in Patients With Colorectal Cancer in Phase 1/2a Open Label Extension Study with Arfolitixorin

Jan 12, 2018

Taiho Oncology Announces Multiple LONSURF® (trifluridine and tipiracil) Presentations at ASCO 2018 Gastrointestinal Cancers Symposium

Jun 29, 2017

ARMO BioSciences Presents Clinical Data on Immunotherapy AM0010 in Advanced Pancreatic Cancer at ESMO World Congress on Gastrointestinal Cancer 2017